Last Updated: February 26, 2021
Result type: Reports
Generic Name: triheptanoin
Indications: Triheptanoin is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders (LC-FAOD).
Last Updated: February 26, 2021
Result type: Reports
Generic Name: tucatinib
Indications: Tucatinib is indicated in combination with trastuzumab and capecitabine for treatment of patients with locally advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received prior treatment with trastuzumab, pertuzumab, and trastuzumab emtansine, separately or in combination.
Last Updated: February 26, 2021
Result type: Reports
Generic Name: apomorphine hydrochloride
Indications: Indicated for the acute, intermittent treatment of “OFF” episodes in patients with Parkinson's disease.
Last Updated: February 26, 2021
Result type: Reports
Generic Name: nintedanib
Indications: Treatment of other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype (also known as progressive fibrosing ILD)
Last Updated: February 26, 2021
Result type: Reports
Research Type: Surgical Procedure
Last Updated: February 25, 2021
Result type: Reports
Generic Name: von Willebrand Factor [recombinant]
Indications: Indicated for: Treatment and Control of bleeding episodes in adults (age ≥18) diagnosed with von Willebrand Disease (VWD).Perioperative management of bleeding in adults (age ≥18) diagnosed with VWD
Last Updated: February 25, 2021
Result type: Reports
Generic Name: romosozumab
Indications: The treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture.
Last Updated: December 23, 2020
Result type: Reports
Generic Name: ofatumumab
Indications: For the treatment
of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical and imaging features.
Last Updated: February 25, 2021
Result type: Reports
Product Line: Pharmaceutical Review Update
See Pharmaceutical Reviews Update – Issue 21 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:
- Update for Patients and Communities
- Revised target dates for pERC meetings
- Revised timelines for posting clinician group input
Last Updated: February 25, 2021
Result type: Reports
Generic Name: risperidone
Indications: Treatment of schizophrenia in adults.
